2840-29-1

Basic information

• Product Name: 3-Amino-4-bromobenzoic acid
• Synonyms: 3-Amino-4-bromobenzoic acid;3-Amino-4-bromobenzoic acid 97%
• CAS NO: 2840-29-1
• Molecular Formula: C₇H₆BrNO₂
• Molecular Weight: 216.03
• Product Categories: Aromatic Amino AcidsCarbonyl Compounds;C7;Carboxylic Acids;Peptide Synthesis;Unnatural Amino Acid Derivatives
• Mol File: 2840-29-1.mol

Chemical Properties

• Melting Point: 226-230 °C
• Boiling Point: 260-230ºC
• Flash Point: 178.2°C
• Appearance: /
• Density: 1.793g/cm³
• Vapor Pressure: 3.69E-06mmHg at 25°C
• Refractive Index: 1.672
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 4.13±0.10(Predicted)
• CAS DataBase Reference: 3-Amino-4-bromobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-4-bromobenzoic acid(2840-29-1)
• EPA Substance Registry System: 3-Amino-4-bromobenzoic acid(2840-29-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 26-36/37
• RIDADR: UN 2811 6.1 / PGIII
• WGK Germany: 3
• Hazardous Substances Data: 2840-29-1(Hazardous Substances Data)

Usage

Chemical Properties

Light yellow powder

InChI:InChI=1/C7H6BrNO2/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3H,9H2,(H,10,11)

Upstream product

• 6319-40-0 4-bromo-3-nitrobenzoic acid 

Downstream Products

• 204782-96-7 8-bromoquinoline-5-carboxylic acid 
• 1126745-42-3 3-sulfinylamino-4-bromobenzoyl chloride 
• 159847-71-9 3-amino-4-cyanobenzoic acid 
• 887757-25-7 4-bromo-3-cyanobenzoic acid 
• 1367551-68-5 3-amino-4-(diphenylphosphoryl)benzoic acid 
• 1585969-87-4 methyl 3-([1,1'-biphenyl]-4-ylcarboxamido)-4-bromobenzoate 
• 1585969-79-4 3-([1,1'-biphenyl]-4-ylcarboxamido)-4-bromobenzoic acid 
• 46064-79-3 2-bromo-5-methoxycarbonylaniline 
• 253787-45-0 methyl 8-bromoquinoline-5-carboxylate 

Relevant articles and documents

Combined muta- and semisynthesis: A powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3

Access of four new tumor specific folic acid/ansamitocin conjugates is reported that relies on a synthetic strategy based on the combination of mutasynthesis and semisynthesis. Two bromo-ansamitocin derivatives were prepared by mutasynthesis or by a modif

2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION

The present invention has its object to provide a 2,3,4,5-tetrahydro-1H-1,5-benzodiazepine derivative represented with the Formula (1) , or the pharmaceutically acceptable salt, which is effective as a therapeutic and prophylactic agent for diabetes, diabetic nephropathy, or glomerulosclerosis.

2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION

A 2,3,4,5-tetrahydro-1H-1,5-benzodiazepine derivative represented by the generalformula (1): [Chemical formula 1] (1) or a pharmaceutically acceptable saltthereof. They are useful as a therapeutic/preventive agent for diabetes, diabeticnephropathy, or glomerulosclerosis.